IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (930)	5/28/1997 11:03:00 AM
From: Roudy	of 1762

Hi Bennett, I appreciate the insights you have provided us on this thread and look forward to your future posts. In regards to CE9.1, could you elude to whether your current concerns are with the present Phase III clinicals or from past completed clinicals? It was just last fall that the analysts had considered CE9.1 in their price projections for IDEC. Given the current price and comparison to last years average share price, it would seem it still is not valued in the stock price. IMO the share price only reflects the value of C2B8 with alot less risk than a year ago. Granted, bad news on CE9.1 would have an effect on the price short term, but would not have a lasting effect since it doesn't seem to be priced into the stock at this time. Again, thank you for your thoughts and actions with IDPH, as it is difficult to make these decisions and be candid with your fellow threadheads. Don

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next